For example, protein-level analyses of tumor specimens suggest that ~60% and ~50% of metastatic melanoma23 and stage III colorectal cancers24, respectively, lose cGAS/STING signaling competence through the repression of cGAS expression, STING expression, or both. The gene discussed is CGAS; the disease is neoplasm.